NEXGEL, Inc. (NXGLW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Les analystes estiment Bénéfice par action (EPS) de $-0.54 et chiffre d'affaires de $0.01B pour le prochain exercice fiscal.
Historique du Bénéfice par action (EPS): 2024: réel $-0.50 vs est $-0.54 (dépassé +7.4%). 2025: réel $-0.38 vs est $-0.35 (manqué -8.6%). Précision des analystes: 92%.
Estimations du BPA — NXGLW
92%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.50
vs Est –$0.54
▲ 8.0% off
2025
Actual –$0.38
vs Est –$0.35
▼ 7.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Estimations du CA — NXGLW
98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.009B
vs Est $0.009B
▲ 0.6% off
2025
Actual $0.011B
vs Est $0.012B
▼ 3.9% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Les autres consultent aussi
